In fact, inhibition in the production of TLR-4, NF-κB p65, COX-2, IL-17, TNF-α, IL-1β, and IL-6 is considered useful in treating colitis (Bribi et al., 2016; Ramos and Papadakis, 2019). Here, NFKB1 is linked to colitis.